BBCvsIWM
Virtus Biotech Clinical Trials ETF against iShares Russell 2000 ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BBC | IWM | |
|---|---|---|
| Expense ratio | 0.65% | 0.19% |
| Assets | $11M | $76.6B |
| Net flow, 1 month | — | −$4.3B |
| Net flow, 1 year | — | −$3.3B |
| Return, YTD | +5.9% | +10.9% |
| Return, 1 year | — | — |
| Avg daily volume | 49K | 23.5M |
| Holdings | 198 | 1970 |
| Listed | Dec 16, 2014 | May 22, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS